Stability of rifampin in SyrSpend SF

Bridget Sorenson1, Paul Whaley

  • 1Dynalabs, LLC, St. Louis, Missouri 63103, USA. bsorenson@dynalabs.us

Insights

This study found that rifampin (a key antibiotic) suspensions are stable for at least 60 days. The drug maintained its concentration when stored at room temperature or refrigerated, protected from light.

Area of Science:

  • Pharmaceutical Sciences
  • Microbiology

Background:

  • Rifampin is a crucial bactericidal antibiotic from the rifamycin group, derived from Streptomyces mediterranei.
  • It is available in various dosage forms, including capsules, tablets, and syrups, often containing alcohol or sorbitol.

Purpose of the Study:

  • To evaluate the stability of rifampin compounded into a 25-mg/mL oral suspension using SyrSpend SF.
  • To establish a beyond-use date for this specific rifampin preparation.

Main Methods:

  • Rifampin suspensions were prepared at 25 mg/mL and stored in low-actinic bottles under room temperature and refrigerated conditions.
  • Stability was assessed over 60 days using a validated, stability-indicating high-performance liquid chromatography (HPLC) method, including forced-degradation studies.

Main Results:

  • Rifampin concentration remained within 90% to 110% of the initial value throughout the 60-day study period.
  • The drug demonstrated stability under both room temperature and refrigerated storage conditions when protected from light.

Conclusions:

  • The compounded rifampin suspension in SyrSpend SF is stable for at least 60 days.
  • A beyond-use date of 60 days is recommended for refrigerated or room temperature storage, provided the preparation is protected from light.

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Drug Product Stability01:16

Drug Product Stability

The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.